BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors

NCT06152757 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Tumors

Interventions

BIOLOGICAL: First dose
BIOLOGICAL: Second dose
BIOLOGICAL: The third dose
BIOLOGICAL: The fourth dose

Sponsor

BioSyngen Pte Ltd

Collaborators

[object Object]